Israa Houjaij
Family · Dearborn, MINPI 1639732787
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $748 and has fallen 97.3% since, to $20 in 2025.
Across 119 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$299
- Novo Nordisk$229
- Axsome Therapeutics, Inc.$168
- GSK$167
- Lilly USA, LLC$166
- Novartis$86
- plus $793 from 19 others
What the payments were for
- Food & beverage$1,909100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $299 |
| Novo Nordisk | 19 | $229 |
| Axsome Therapeutics, Inc. | 6 | $168 |
| GSK | 13 | $167 |
| Lilly USA, LLC | 11 | $166 |
| Novartis | 6 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $80 |
| Ironwood Pharmaceuticals, Inc | 5 | $76 |
| AstraZeneca | 5 | $76 |
| Boehringer Ingelheim | 3 | $72 |
| Pfizer | 3 | $68 |
| Nestle Healthcare Nutrition Inc. | 5 | $66 |
| Amgen | 3 | $52 |
| Merck | 3 | $51 |
| Redhill Biopharma Inc. | 3 | $46 |
| Bayer | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Corcept Therapeutics | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Ardelyx, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $13 |
How this compares
$1,909 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meclizine Hcl | 16 | $92 |
| Ezetimibe | 11 | $77 |
| Alendronate Sodium | 16 | $51 |
| Atorvastatin Calcium | 11 | $50 |
| Doxazosin Mesylate | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other family in Dearborn
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.